Professor of Medicine Thoracic Oncology UCSF-Helen Diller Family Comprehensive Cancer Center
Oncology
Dr. Thierry M. Jahan, MD
|
|
Give Review
Dr. Thierry M. Jahan works in the field of Oncology. He went to George Washington University School of Medicine. George Washington University School of Medicine has a rank of 67 in research and a 0 in primary care He received 4 awards: "CMS Meaningful Use Stage 1 Certification", "America's Top Doctors", "America's Top Doctors for Cancer" and "Top MD". Doctor Thierry M. Jahan, MD is a published doctor and has 39 publications published. The lastest was: 'Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264.' He accepts Medicare.
Publications
- Prognostic molecular assay might improve identification of patients at risk for recurrence in early-stage non-small-cell lung Cancer.
- A Phase II, Open-Label Study of Ramucirumab in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Patients with Stage IIIB/IV Non-Small-Cell Lung Can...
- The impact of a fourteen-gene molecular assay on physician treatment decisions in non-small-cell lung Cancer.
- Aggressive and minimally invasive surgery for pulmonary metastasis of Sarcoma.
- Divergent Management Strategies for Typical Versus Atypical Carcinoid Tumors of the Thoracic Cavity.
- Determination of Cutpoints for Low and High Number of Symptoms in Patients with Advanced Cancer.
- One size does not fit all lung Cancer patients.
- Impact of Age and Comorbidity on Non-Small-Cell Lung Cancer Treatment in Older Veterans.
- Malignant pleural mesothelioma. Clinical practice guidelines in oncology.
- Implications of Delayed Initiation of Radiotherapy: Accelerated Repopulation after Induction Chemotherapy for Stage III Non-small Cell Lung Cancer.
- Lung Cancer stigma, depression, and quality of life among ever and never smokers.
- Measuring stigma in people with lung Cancer: psychometric testing of the cataldo lung Cancer stigma scale.
- A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignancies.
- Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung Cancer.
- Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung Cancer.
- Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung Cancer: clinical...
- Malignant pheochromocytomas and paraganGliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
- Unusual thoracic problems in patients with malignancies: case 3. Carcinoid tumor of the thymus.
- Mechanisms of and potential treatment strategies for metastatic disease in non-small cell lung Cancer.
- Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for Malignant pleural mesothelioma.
- Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung Cancer (NSCLC): results from a prospective analysis using the Lung Cancer S...
- A review of the prevalence and impact of multiple symptoms in oncology patients.
- Changes in symptom clusters in patients undergoing radiation therapy.
- Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory l...
- Non-small cell lung Cancer clinical practice guidelines in oncology.
- Small cell lung Cancer clinical practice guidelines in oncology.
- A review of the literature on multiple symptoms, their predictors, and associated outcomes in patients with advanced Cancer.
- Emerging antiangiogenic therapies for non-small-cell lung Cancer.
- Differences in symptom clusters identified using occurrence rates versus symptom severity ratings in patients at the end of radiation therapy.
- Non-small cell lung Cancer.
- Thymic malignancies.
- Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264.
- Treatment of metastatic Cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.
- Stage II (N1) lung Cancer.
- Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX vaccine in advanced-stage non-small-cell lung Cancer.
- Resection and IORT followed by three-dimensional conformal radiotherapy with or without adjuvant chemotherapy for Malignant mesothelioma.
- NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016.
- A phase I trial of panobinostat and epirubicin in solid Tumors with a dose expansion in patients with sarcoma.
Schools
George Washington University School Of Medicine
Cedars Sinai Med Center
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bladder Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors
- America's Top Doctors for Cancer
- Top MD
Education
-
Cedars-Sinai Medical Center -
George Washington University School of Medicine
Hospital
-
San Francisco General Hospital and Trauma Center -
UCSF Medical Center
Drug Facts
| NPI NUMBER | 1427007657 | |
| NPPES Provider LastName | JAHAN | |
| NPPES Provider FirstName | THIERRY | |
| NPPES Provider ZIPCode | 941153010 | |
| NPPES Provider State | CA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 443.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 58.0 | |
| Percent Opioid Claims | 13.09 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1427007657 |
| Last Name Of The Provider | JAHAN |
| First Name Of The Provider | THIERRY |
| View All |
Similar Doctors
|
|
Dr. Jeffrey L. Wolf, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bertrand Y. Tuan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Collin M. Blakely, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark M. Moasser, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ari D. Baron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joan E. Etzell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew C. Hsieh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Isaac C. Henderson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Derek Kerr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marc A. Shuman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Margaret A. Tempero, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew H. Ko, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jennifer L. Caswell, MD |
|
|
Dr. Judy M. Cheng, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James M. Kahn, DO |
|
|
Dr. Sue Kim, MD |
|
|
Dr. Frank A. Scappaticci, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melisa L. Wong, MD
This Doctor is OpenDoctor Recommended.
|